|
|
|
Volumn 62 Suppl 5, Issue , 2004, Pages 364-367
|
|
The trend in the development of the active vitamin D3 and its analogues
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 ALPHA HYDROXYERGOCALCIFEROL;
1 ALPHA-HYDROXYERGOCALCIFEROL;
1-HYDROXYCHOLECALCIFEROL;
2 (3 HYDROXYPROPOXY) 1,25 DIHYDROXYVITAMIN D3;
2-(3-HYDROXYPROPOXY)-1,25-DIHYDROXYVITAMIN D3;
22 OXACALCITRIOL;
26,26,26,27,27,27-HEXAFLUORO-1,25-DIHYDROXYVITAMIN D3;
ALFACALCIDOL;
CALCITRIOL;
COLECALCIFEROL;
DRUG DERIVATIVE;
ERGOCALCIFEROL;
FALECALCITRIOL;
HYDROXYCOLECALCIFEROL;
PARICALCITOL;
CHRONIC KIDNEY FAILURE;
DRUG DESIGN;
HUMAN;
REVIEW;
SECONDARY HYPERPARATHYROIDISM;
CALCITRIOL;
CHOLECALCIFEROL;
DRUG DESIGN;
ERGOCALCIFEROLS;
HUMANS;
HYDROXYCHOLECALCIFEROLS;
HYPERPARATHYROIDISM, SECONDARY;
KIDNEY FAILURE, CHRONIC;
|
|
EID: 4344598223
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (16)
|
